INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 120 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,730,662 | -22.2% | 52,422 | -5.4% | 0.01% | -16.7% |
| Q2 2023 | $3,509,891 | +16.9% | 55,431 | 0.0% | 0.01% | +9.1% |
| Q1 2023 | $3,001,589 | +2.3% | 55,431 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $2,933,409 | +18.9% | 55,431 | +4.6% | 0.01% | +10.0% |
| Q3 2022 | $2,467,000 | -18.5% | 53,010 | 0.0% | 0.01% | -9.1% |
| Q2 2022 | $3,026,000 | -6.7% | 53,010 | 0.0% | 0.01% | +10.0% |
| Q1 2022 | $3,244,000 | -11.1% | 53,010 | -24.0% | 0.01% | -9.1% |
| Q4 2021 | $3,650,000 | +6.8% | 69,728 | -23.9% | 0.01% | 0.0% |
| Q3 2021 | $3,418,000 | +25.8% | 91,672 | +37.7% | 0.01% | +22.2% |
| Q2 2021 | $2,718,000 | +25.7% | 66,586 | +4.5% | 0.01% | +12.5% |
| Q1 2021 | $2,163,000 | -17.2% | 63,743 | -22.4% | 0.01% | -11.1% |
| Q4 2020 | $2,612,000 | +21.4% | 82,133 | -2.0% | 0.01% | 0.0% |
| Q2 2020 | $2,152,000 | +177.3% | 83,840 | +34.1% | 0.01% | +200.0% |
| Q2 2017 | $776,000 | -23.6% | 62,500 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $1,016,000 | +7.7% | 62,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $943,000 | -1.0% | 62,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $953,000 | -60.7% | 62,500 | 0.0% | 0.00% | -63.6% |
| Q2 2016 | $2,426,000 | +39.6% | 62,500 | 0.0% | 0.01% | +37.5% |
| Q1 2016 | $1,738,000 | -74.2% | 62,500 | -50.0% | 0.01% | -42.9% |
| Q4 2015 | $6,724,000 | +168.6% | 125,000 | +100.0% | 0.01% | +27.3% |
| Q3 2015 | $2,503,000 | +74.1% | 62,500 | +38.9% | 0.01% | +83.3% |
| Q2 2015 | $1,438,000 | +33.8% | 45,000 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $1,075,000 | +35.4% | 45,000 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $794,000 | +28.7% | 45,000 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $617,000 | -18.7% | 45,000 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $759,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
| Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
| Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
| Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
| Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
| Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
| WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
| Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |